The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A - PubMed (original) (raw)

. 1999 Nov 2;264(3):871-7.

doi: 10.1006/bbrc.1999.1605.

Affiliations

• PMID: 10544023
• DOI: 10.1006/bbrc.1999.1605

The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A

S R Chakrabarti et al. Biochem Biophys Res Commun. 1999.

Abstract

The E-26 transforming specific (ETS)-related gene TEL, also known as ETV6, encodes a strong transcription repressor that is rearranged in several recurring chromosomal rearrangements associated with leukemia and congenital fibrosarcoma. The TEL protein contains two functional domains that have been partially characterized: a helix-loop-helix (HLH) domain (also known as a pointed domain) at the N-terminus, which physically interacts with itself, with the SUMO-conjugating enzyme UBC9, and with FLI1; and, at the C-terminus, an ETS domain with DNA-binding properties. Little is known about the function of the central region of TEL. The HLH domain and the central region of TEL are consistently maintained in the t(12;21), which is the most frequent chromosomal translocation involving TEL. In this study, we found that the HLH domain and the central region of TEL mediate transcription repression by two distinct mechanisms. The central region involves the recruitment of a repression complex, including SMRT and mSin3A. The HLH domain represses gene transcription through a mechanism that is independent of known corepressors. Thus, TEL belongs to a growing number of transcription factors rearranged by chromosomal translocations that are associated with the corepressor complexes.

Copyright 1999 Academic Press.

PubMed Disclaimer

Similar articles

• Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9.
  Chakrabarti SR, Sood R, Ganguly S, Bohlander S, Shen Z, Nucifora G. Chakrabarti SR, et al. Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7467-72. doi: 10.1073/pnas.96.13.7467. Proc Natl Acad Sci U S A. 1999. PMID: 10377438 Free PMC article.
• TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3.
  Wang L, Hiebert SW. Wang L, et al. Oncogene. 2001 Jun 21;20(28):3716-25. doi: 10.1038/sj.onc.1204479. Oncogene. 2001. PMID: 11439334
• The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.
  Wai DH, Knezevich SR, Lucas T, Jansen B, Kay RJ, Sorensen PH. Wai DH, et al. Oncogene. 2000 Feb 17;19(7):906-15. doi: 10.1038/sj.onc.1203396. Oncogene. 2000. PMID: 10702799
• Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins.
  Heibert SW, Lutterbach B, Durst K, Wang L, Linggi B, Wu S, Wood L, Amann J, King D, Hou Y. Heibert SW, et al. Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S31-4. doi: 10.1007/s002800100302. Cancer Chemother Pharmacol. 2001. PMID: 11587363 Review.
• Proteins of the ETS family with transcriptional repressor activity.
  Mavrothalassitis G, Ghysdael J. Mavrothalassitis G, et al. Oncogene. 2000 Dec 18;19(55):6524-32. doi: 10.1038/sj.onc.1204045. Oncogene. 2000. PMID: 11175368 Review.

Cited by

• The Diverse Roles of ETV6 Alterations in B-Lymphoblastic Leukemia and Other Hematopoietic Cancers.
  Monovich AC, Gurumurthy A, Ryan RJH. Monovich AC, et al. Adv Exp Med Biol. 2024;1459:291-320. doi: 10.1007/978-3-031-62731-6_13. Adv Exp Med Biol. 2024. PMID: 39017849 Review.
• The Impact of ETV6-NTRK3 Oncogenic Gene Fusions on Molecular and Signaling Pathway Alterations.
  Kinnunen M, Liu X, Niemelä E, Öhman T, Gawriyski L, Salokas K, Keskitalo S, Varjosalo M. Kinnunen M, et al. Cancers (Basel). 2023 Aug 24;15(17):4246. doi: 10.3390/cancers15174246. Cancers (Basel). 2023. PMID: 37686522 Free PMC article.
• Sticky, Adaptable, and Many-sided: SAM protein versatility in normal and pathological hematopoietic states.
  Ray S, Hewitt K. Ray S, et al. Bioessays. 2023 Aug;45(8):e2300022. doi: 10.1002/bies.202300022. Epub 2023 Jun 15. Bioessays. 2023. PMID: 37318311 Free PMC article. Review.
• The ETS transcription factor ETV6 constrains the transcriptional activity of EWS-FLI to promote Ewing sarcoma.
  Lu DY, Ellegast JM, Ross KN, Malone CF, Lin S, Mabe NW, Dharia NV, Meyer A, Conway A, Su AH, Selich-Anderson J, Taslim C, Byrum AK, Seong BKA, Adane B, Gray NS, Rivera MN, Lessnick SL, Stegmaier K. Lu DY, et al. Nat Cell Biol. 2023 Feb;25(2):285-297. doi: 10.1038/s41556-022-01059-8. Epub 2023 Jan 19. Nat Cell Biol. 2023. PMID: 36658220 Free PMC article.
• Germline ETV6 mutation promotes inflammation and disrupts lymphoid development of early hematopoietic progenitors.
  Zhou C, Uluisik R, Rowley JW, David C, Jones CL, Scharer CD, Noetzli L, Fisher MH, Kirkpatrick GD, Bark K, Boss JM, Henry CJ, Pietras EM, Di Paola J, Porter CC. Zhou C, et al. Exp Hematol. 2022 Aug-Sep;112-113:24-34. doi: 10.1016/j.exphem.2022.06.002. Epub 2022 Jul 6. Exp Hematol. 2022. PMID: 35803545 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal